Ims Capital Management Edwards Lifesciences Corp Transaction History

Ims Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 12, 2021	SELL	$71.69 - $91.23 $457,023 - $581,591	-6,375 Closed	0 $0
Q2 2020 Jul 15, 2020	BUY	$57.54 - $76.95 $244,545 - $327,037	4,250 Added 200.0%	6,375 $441,000
Q3 2019 Oct 09, 2019	SELL	$61.55 - $75.43 $130,793 - $160,288	-2,125 Reduced 50.0%	2,125 $467,000
Q4 2018 Feb 07, 2019	SELL	$46.41 - $56.94 $81,217 - $99,645	-1,750 Reduced 29.17%	4,250 $651,000
Q2 2018 Jul 26, 2018	SELL	$42.45 - $51.3 $46,695 - $56,430	-1,100 Reduced 15.49%	6,000 $873,000
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $257,659 - $275,693	7,100	7,100 $776,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Ims Capital Management, based on Form 13F filings with the SEC.

Stay updated on Ims Capital Management with notifications on news.